APA način citiranja

Panayiotidis, P., Follows, G. A., Mollica, L., Nagler, A., Özcan, M., Santoro, A., . . . Dreyling, M. (2021). Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma. Blood Adv.

Čikaški stil citiranja

Panayiotidis, Panayiotis, et al. "Efficacy and Safety of Copanlisib in Patients With Relapsed or Refractory Marginal Zone Lymphoma." Blood Adv 2021.

MLA način citiranja

Panayiotidis, Panayiotis, et al. "Efficacy and Safety of Copanlisib in Patients With Relapsed or Refractory Marginal Zone Lymphoma." Blood Adv 2021.